SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-18-064823
Filing Date
2018-12-17
Accepted
2018-12-17 12:48:32
Documents
2
Group Members
CORA MADSENFLORIAN SCHONHARTINGNB PUBLIC EQUITY KOMPLEMENTAR APS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv509190_sc13ga.htm SC 13G/A 74974
2 EXHIBIT 99.1 tv509190_ex99-1.htm EX-99.1 10292
  Complete submission text file 0001144204-18-064823.txt   87197
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43381 | Film No.: 181237561
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OESTERGADE 24A,1 DK-1100 COPENHAGEN G7 -----
Business Address OESTERGADE 24A,1 DK-1100 COPENHAGEN G7 ----- 45 70 20 12 63
NB Public Equity K/S (Filed by) CIK: 0001451330 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A